Merus Stock (NASDAQ:MRUS), Quotes and News Summary

Q: What sector and industry does Merus (MRUS) operate in?

Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Merus Stock (NASDAQ: MRUS) stock price, news, charts, stock research, profile.

Open	$41.380
Close	-
Volume / Avg.	4.452K / 570.047K
Day Range	40.640 - 41.380
52 Wk Range	18.210 - 52.035
Market Cap	$2.409B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	5.89%
Days to Cover	6.42

Recent News

AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst

On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients

Vandana Singh

Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy

Vandana Singh

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional investors at $2.48 per share.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Merus (MRUS) stock?

You can purchase shares of Merus (NASDAQ: MRUS) through any online brokerage.

View our list of the best stock brokerages.

Who are Merus's (MRUS) competitors?

There are no as such competitors for Merus.

What is the target price for Merus (MRUS) stock?

The latest price target for Merus (NASDAQ: MRUS) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 66.00 expecting MRUS to rise to within 12 months (a possible 60.78% upside). 25 analyst firms have reported ratings in the last year.

Current Stock Price for Merus (MRUS)?

The stock price for Merus (NASDAQ: MRUS) is $41.05 last updated April 17, 2024 at 4:20 PM EDT.

Does Merus (MRUS) pay a dividend?

There are no upcoming dividends for Merus.

When is Merus (NASDAQ:MRUS) reporting earnings?

Merus’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Is Merus (MRUS) going to split?

There is no upcoming split for Merus.

What sector and industry does Merus (MRUS) operate in?

Merus is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.